Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
ACTIVE NOT RECRUITING
NCT07071532
PHASE1

A Study to Assess Adverse Events and How Oral ABBV-932 Moves Through the Body When Given With Oral Itraconazole in Healthy Adult Participants

Sponsor: AbbVie

View on ClinicalTrials.gov

Summary

This study will assess the adverse events and how oral ABBV-932 moves through the body when given with oral Itraconazole in healthy Adults participants.

Official title: A Phase 1 Study to Evaluate the Effect of Itraconazole on the Pharmacokinetics of ABBV-932 in Healthy Adult Subjects

Key Details

Gender

All

Age Range

18 Years - 65 Years

Study Type

INTERVENTIONAL

Enrollment

20

Start Date

2025-07-15

Completion Date

2025-11

Last Updated

2025-09-10

Healthy Volunteers

Yes

Interventions

DRUG

ABBV-932

Oral Capsule

DRUG

Itraconazole

Oral Capsule

Locations (1)

Acpru /Id# 276951

Grayslake, Illinois, United States